Dopamine receptor and dopamine transporter in obesity: A meta‐analysis

The brain plays a major role in controlling the desire to eat. This meta‐analysis aimed to assess the association between dopamine receptor (DR) availability and dopamine transporter (DAT) availability, measured using positron emission tomography, and obesity. We performed a systematic search of MEDLINE (from inception to November 2020) and EMBASE (from inception to November 2020) for articles published in English using the keywords “dopamine receptor,” “dopamine transporter,” “obesity,” and “neuroimaging.” Body mass index (BMI) and the corresponding binding potential (BPND) were extracted from figures in each study using Engauge Digitizer, version 12.1, and plotted for radiopharmaceuticals and regions of interest (ROIs). Five studies involving 119 subjects with DR and five studies including 421 subjects with DAT were eligible for inclusion in this study. In overweight or obese subjects with BMI of 25 kg/m2 or higher, DR availability from 11C‐Racloprie was negatively associated with BMI. However, DR availability from 11C‐PHNO was positively associated with BMI. DAT ratio was calculated after dividing DAT availabilities of overweight/obese BMI with mean DAT availabilities of normal BMI. The association between DAT ratio and BMI was not significant regardless of radiopharmaceuticals. In conclusion, dopamine plays a main role in the reward system with regard to obesity. Overweight and obese subjects had negative association between DR availability from 11C‐Raclopride and BMI. However, the association of DR availability with BMI was dependent on radiopharmaceuticals. DAT availability did not show the significant relationship with BMI regardless of radiopharmaceuticals.

[1]  Myung Jun Lee,et al.  SLC6A3 gene polymorphisms are associated with striatal dopamine transporter changes after glucose loading , 2022, Synapse.

[2]  K. Pak,et al.  Dopamine transporter in obesity: a meta-analysis , 2021, medRxiv.

[3]  Myung Jun Lee,et al.  Striatal dopamine transporter changes after glucose loading in humans , 2019, Diabetes, obesity & metabolism.

[4]  L. Nummenmaa,et al.  μ-opioid receptor system mediates reward processing in humans , 2018, Nature Communications.

[5]  Kyoungjune Pak,et al.  The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters , 2018, Scientific Reports.

[6]  Kyoungjune Pak,et al.  The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters , 2018, Scientific Reports.

[7]  Kyoungjune Pak,et al.  Obesity and Brain Positron Emission Tomography , 2018, Nuclear Medicine and Molecular Imaging.

[8]  S. L. la Fleur,et al.  The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. , 2017, Metabolism: clinical and experimental.

[9]  L. Nummenmaa,et al.  Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity , 2016, Molecular Psychiatry.

[10]  P. Worhunsky,et al.  Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO , 2016, Neuropsychopharmacology.

[11]  E. Aarts,et al.  Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity , 2015, NeuroImage: Clinical.

[12]  L. Nummenmaa,et al.  Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain , 2015, The Journal of Neuroscience.

[13]  Alan A. Wilson,et al.  Ventral Striatum Binding of a Dopamine D2/3 Receptor Agonist But Not Antagonist Predicts Normal Body Mass Index , 2015, Biological Psychiatry.

[14]  W. K. Simmons,et al.  Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior , 2014, Molecular Psychiatry.

[15]  D. Zald,et al.  Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity , 2014, Synapse.

[16]  Ann W. Kinyua,et al.  Leptin and insulin signaling in dopaminergic neurons: relationship between energy balance and reward system , 2014, Front. Psychol..

[17]  Michael W. Schwartz,et al.  Neurobiology of food intake in health and disease , 2014, Nature Reviews Neuroscience.

[18]  T. Iseli,et al.  Non-viral causes of liver cancer: does obesity led inflammation play a role? , 2014, Cancer letters.

[19]  Yiyun Huang,et al.  Imaging Nicotine- and Amphetamine-Induced Dopamine Release in Rhesus Monkeys with [11C]PHNO vs [11C]raclopride PET , 2014, Neuropsychopharmacology.

[20]  K. Black,et al.  A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol , 2013, Synapse.

[21]  J. Foster,et al.  Mechanisms of dopamine transporter regulation in normal and disease states. , 2013, Trends in pharmacological sciences.

[22]  M. Karin,et al.  Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. , 2013, Gastroenterology.

[23]  Nora D. Volkow,et al.  The Addictive Dimensionality of Obesity , 2013, Biological Psychiatry.

[24]  Marco Pagani,et al.  No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers , 2013, NeuroImage.

[25]  Corby K. Martin,et al.  Sweetness, satiation, and satiety. , 2012, The Journal of nutrition.

[26]  J. Lammertyn,et al.  How is reward sensitivity related to bodyweight in children? , 2012, Appetite.

[27]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[28]  Jean Logan,et al.  Enhanced Striatal Dopamine Release During Food Stimulation in Binge Eating Disorder , 2011, Obesity.

[29]  G. Knudsen,et al.  Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123I-FP-CIT and 123I-PE2I , 2010, The Journal of Nuclear Medicine.

[30]  N. Volkow,et al.  Decreased dopamine type 2 receptor availability after bariatric surgery: Preliminary findings , 2010, Brain Research.

[31]  James Robert Brašić,et al.  Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery , 2010, Obesity surgery.

[32]  J. V. van Vliet-Ostaptchouk,et al.  Genetic variation in the hypothalamic pathways and its role on obesity , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[33]  J. Hebebrand,et al.  [Obesity and overweight]. , 2009, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

[34]  Yu-Shin Ding,et al.  Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors , 2008, NeuroImage.

[35]  K. Watson,et al.  The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. , 2008, Archives of internal medicine.

[36]  Ariel Graff-Guerrero,et al.  Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C]raclopride in healthy humans , 2008, Human brain mapping.

[37]  Nan-Tsing Chiu,et al.  Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers—A SPECT study , 2008, NeuroImage.

[38]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].

[39]  Kyle S. Smith,et al.  Hedonic Hot Spots in the Brain , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[40]  Jean Logan,et al.  Brain dopamine and obesity , 2001, The Lancet.

[41]  K. Berridge.  Food reward: Brain substrates of wanting and liking , 1996, Neuroscience & Biobehavioral Reviews.

[42]  V. Routh,et al.  Role of the brain in energy balance and obesity. , 1996, The American journal of physiology.

[43]  K. Zhao,et al.  Obesity-associated endometrial and cervical cancers. , 2013, Frontiers in bioscience.

[44]  T. Pischon,et al.  Obesity and colorectal cancer. , 2013, Frontiers in bioscience.

[45]  R. Payne,et al.  Obesity and thyroid cancer. , 2011, Frontiers in bioscience.

[46]  K. Frey,et al.  In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations. , 2010, Nuclear medicine and biology.

[47]  O. Hornykiewicz.  Limbic Mechanisms , 1978, Springer US.